Venture capital-backed Atara Biotherapeutics Inc., (NASDAQ:ATRA) whose lead product addresses muscle loss, filed Wednesday to raise roughly $74 million in a follow-on offering three months after a disappointing initial public offering, marking the latest life sciences firm to return to the public markets to fund research and development. On Thursday shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) closed at $24.45.
Cross Country Healthcare, Inc. (NASDAQ:CCRN) in last trading activity moved up 6.34% to close at $10.73. Company weekly performance is -2.98% while its quarterly performance stands at 14.15%. Cross Country Healthcare, Inc. (NASDAQ:CCRN) is -20.58% away from its 52 week high.
Cheniere Energy Partners, LP (NYSEMKT:CQP) cash dividend payment of $0.425 per share is scheduled to be paid on February 13, 2015. On last trading day Cheniere Energy Partners LP. (NYSEMKT:CQP) moved up 0.38% to close at $31.47. Its volatility for the week is 3.44% while volatility for the month is 3.96%. CQP’s sales growth for past 5 years was 78.00% and its EPS growth for past 5 years was -10.40%. Cheniere Energy Partners LP. (NYSEMKT:CQP) monthly performance is -0.03%.
General Growth Properties Inc (NYSE:GGP) reported results for the fourth quarter ended December 31, 2014. Total revenue came in at $673.022 million, above estimates of $671.69 million and the $670.665 million reported in the prior year period. Company funds from operations (“Company FFO”) per share increased 5.1 percent from the prior year period to $0.38 per diluted share, in line with expectations. General Growth Properties, Inc (NYSE:GGP) has 0.10% insider ownership while its institutional ownership stands at 97.20%. In last trading activity company’s stock closed at $30.94.
Accuride Corp., (NYSE:ACW) on 27 January said Rick Dauch, its president and chief executive officer, has been elected for a three-year term to the Heavy Duty Manufacturers Association (HDMA) board of directors. On last trading day Accuride Corp. (NYSE:ACW) moved up 1.16% to close at $4.36. Its volatility for the week is 2.93% while volatility for the month is 3.68%. ACW’s sales growth for past 5 years was -7.10% and its EPS growth for past 5 years was 64.10%. Accuride Corp. (NYSE:ACW) monthly performance is -2.24%.